| 摘要 |
Provided are compounds of general formula (I), wherein R2 is selected from the group consisting of H, F, Cl, (Ñ1-4) alkyl, (C3-4)cycloalkyl and ÑF3; R4 is H or Me; R5 is H, Me or Et, with the proviso that R4 and R5 are not both Me, and if R4 is Me then R5 cannot be Et; R11 is Et, cyclopropyl, propyl, isopropyl, or isobutyl; and Q is selected from the group consisting of (II), (III), (IV) and (V); and pharmaceutically acceptable salts thereof, as inhibitors of HIV reverse transcriptase, wild-type and several mutant strains. (I) (II), (III), (IV), 3 (V)
|
